Klaus Okkenhaug
klausokken.bsky.social
Professor of Immunology, Department of Pathology, University of Cambridge. Research interests: PI3K, immunity, infection, cancer, immunotherapy.
👤 Joined on 18 December 2023
3212
Followers
460
Following
31
Total Posts
📜 Kullanıcı Geçmişi
- 18 Ara 2023, 09:33
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@klausokken.bsky.social
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
Karl Deisseroth, Peter Hegemann and Georg Nagel win the 2026 Nobel Prize in Physiology or Medicine for their work on optogenetics, which has revolutionized neuroscience go.nature.com/4yBpO9O
Show Post
Delighted to share new work published in @science.org entitled 'Tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species,' led by @xanwesolowski.bsky.social in the lab science.org/eprint/YQNFA...
Show Post
I would also like to thank @klausokken.bsky.social for the help with testing the effect of VPS34 on T cell homing in vivo. @thorstenschaefer.bsky.social made me test the effect of these kinases on cell migration in the first place and all other coauthors who are not on this platform!
Show Post
RFK Jr. says that HPV vaccine is “dangerous and defective”. A new study from England shows that HPV vaccines have reduced deaths from cervical cancer to ZERO for women aged 20-24. Significant reductions in older age groups were observed as well, though the latter have lower vaccination coverage.
Show Post